Literature DB >> 27665170

Amyloidogenesis of the amylin analogue pramlintide.

Dayana Cabral da Silva1, Giselle N Fontes2, Luiza C S Erthal1, Luís Maurício T R Lima3.   

Abstract

Amylin is a pancreatic peptide hormone co-secreted along with insulin by the β-cells. It is found in amyloid deposits in both type 2 diabetic individuals and elder non-diabetic. The triple proline amylinomimetic compound (25,28,29-Pro-human amylin) named pramlintide was designed aiming to solve the solubility and amyloid characteristics of human amylin. We have found by using ion mobility spectrometry-based mass spectrometry that pramlintide is able to assembly into multimers. Pramlintide formed amyloid fibrils in vitro in a pH-dependent kinetic process within a few hours, as followed by thioflavin T, quantification of soluble peptide and further characterized by transmission electron microscopy, atomic force microscopy and X-ray diffraction. These data indicate that pramlintide can form amyloid fibers.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amylin; Amyloid; Diabetes; Islet associated polypeptide; Pramlintide

Mesh:

Substances:

Year:  2016        PMID: 27665170     DOI: 10.1016/j.bpc.2016.09.007

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  11 in total

1.  Synergistic long-range effects of mutations underlie aggregation propensities of amylin analogues.

Authors:  Nelson A Alves; Luis G Dias; Rafael B Frigori
Journal:  J Mol Model       Date:  2019-08-19       Impact factor: 1.810

2.  d-Retro Inverso Amylin and the Stability of Amylin Fibrils.

Authors:  Preeti Pandey; Natalie Nguyen; Ulrich H E Hansmann
Journal:  J Chem Theory Comput       Date:  2020-07-28       Impact factor: 6.006

3.  Microcanonical insights into the physicochemical stability of the coformulation of insulin with amylin analogues.

Authors:  Rafael B Frigori; Fabio Rodrigues
Journal:  J Mol Model       Date:  2021-01-07       Impact factor: 1.810

4.  Analysis of Proline Substitutions Reveals the Plasticity and Sequence Sensitivity of Human IAPP Amyloidogenicity and Toxicity.

Authors:  Zachary Ridgway; Charles Eldrid; Alexander Zhyvoloup; Aisha Ben-Younis; Daeun Noh; Konstantinos Thalassinos; Daniel P Raleigh
Journal:  Biochemistry       Date:  2020-01-30       Impact factor: 3.162

5.  Heterotropic Modulation of Amylin Fibrillation by Small Molecules: Implications for Formulative Designs.

Authors:  Celimar Sinézia; Luís Maurício T R Lima
Journal:  Protein J       Date:  2020-02       Impact factor: 2.371

6.  The toxic nature of murine amylin and the immune responsivity of pancreatic islet to conformational antibody in mice.

Authors:  Luiza C S Erthal; Luana Jotha-Mattos; Flávio Alves Lara; Sabrina Alves Dos Reis; Bernardo Miguel de Oliveira Pascarelli; Cinthia Melo Costa; Kleber L A Souza; Luís Maurício T R Lima
Journal:  Mol Cell Biochem       Date:  2018-01-25       Impact factor: 3.396

7.  Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Yong-Chao Qiao; Wei Ling; Yan-Hong Pan; Yin-Ling Chen; Dan Zhou; Yan-Mei Huang; Xiao-Xi Zhang; Hai-Lu Zhao
Journal:  Oncotarget       Date:  2017-03-08

8.  Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells.

Authors:  Prashant Bharadwaj; Tanya Solomon; Bikash R Sahoo; Katarzyna Ignasiak; Scott Gaskin; Joanne Rowles; Giuseppe Verdile; Mark J Howard; Charles S Bond; Ayyalusamy Ramamoorthy; Ralph N Martins; Philip Newsholme
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

9.  Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells.

Authors:  Terenzio Congiu; Mawadda Alghrably; Abdul-Hamid Emwas; Lukasz Jaremko; Joanna I Lachowicz; Marco Piludu; Monica Piras; Gavino Faa; Giuseppina Pichiri; Mariusz Jaremko; Pierpaolo Coni
Journal:  Pharmaceutics       Date:  2021-06-03       Impact factor: 6.321

10.  A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs.

Authors:  Caitlin L Maikawa; Anton A A Smith; Lei Zou; Gillie A Roth; Emily C Gale; Lyndsay M Stapleton; Sam W Baker; Joseph L Mann; Anthony C Yu; Santiago Correa; Abigail K Grosskopf; Celine S Liong; Catherine M Meis; Doreen Chan; Megan Troxell; David M Maahs; Bruce A Buckingham; Matthew J Webber; Eric A Appel
Journal:  Nat Biomed Eng       Date:  2020-05-11       Impact factor: 25.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.